Noting that the sample size was "too small" for a Phase IV study of Vonoprazan Tablets 10 mg and 20 mg, the Subject Expert ...

Zalunfiban, a glycoprotein IIb/IIIa inhibitor specifically formulated for rapid subcutaneous administration, has been ...

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing therapeutics to modify ...

Detailed price information for Vistagen Therapeutics Inc (VTGN-Q) from The Globe and Mail including charting and trades.

A secretive national trial of puberty blockers for children is facing a High Court challenge amid claims that the "powerful ...

Data from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and cardiovascular toxicities commonly associated with tacrol ...

BrainXell, Inc. today announced that data will be presented during poster sessions at the 2025 Society for Neuroscience (SfN) ...

Dr Moni Abraham Kuriakose –co-founder, medical director, and CEO of Karkinos Kerala – is a leading surgical oncologist and ...

The study follows 45 Nova survivors who were under the influence of a psychoactive substance during the massacre as they ...

Unsupervised GLP-1 use rises in India as structured, doctor-led platforms like Early.Fit push for safer, science-backed ...

Maryanne Perrin, an associate professor of nutrition. The study has been published in the American Journal of Clinical Nutrition. The researchers collected and analyzed 600 milk samples from approved ...

A Wound That Will Not Heal The confrontation between Federal Capital Territory Minister Nyesom Ezenwo Wike and Naval ...